These data suggest that inhibition of all dicarboxylate transporters in general through mersalyl acid, but unlikely the specific blockage of NaDC3 alone, interferes with succinate uptake and S-pathway capacity in PTEN− prostate cancer cells. Here, SLC13A3 is linked to prostate cancer.